tradingkey.logo
搜尋

electroCore, Inc.

ECOR
添加自選
8.445USD
+0.145+1.75%
收盤 07/02, 13:00美東報價延遲15分鐘
67.60M總市值
虧損本益比TTM

electroCore, Inc.

8.445
+0.145+1.75%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.75%

5天

+11.56%

1月

-18.41%

6月

+88.29%

今年開始到現在

+88.29%

1年

+61.16%

關鍵數據
8.390今開
8.840最高
34.51K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.43%換手率
8.300昨收
7.905最低
145.10K成交額
虧損本益比靜
-39.55市淨率
0.00%股息率 TTM
-97.59%ROA
9.68052週最高
0.80量比
-11.89M淨利潤
8.00M總股本
-1.7700每股盈餘TTM
0.79Beta
-478.70%ROE
4.16052週最低
11.27%振幅
87.27%毛利率
67.60M總市值
-2.27回報/風險
5.37%風險率

TradingKey electroCore, Inc.股票評分

單位: USD 更新時間: 2026-07-01

操作建議

electroCore, Inc.當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名85/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為19.17。中期看,股價處於上升通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

electroCore, Inc.評分

相關信息

行業排名
85 / 204
全市場排名
224 / 4564
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看好

electroCore, Inc.亮點

亮點風險
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
業績高增長
公司營業收入穩步增長,連續3年增長99.83%
業績增長期
公司處於發展階段,最新年度總收入32.03M美元
估值低估
公司最新PE估值-4.69,處於3年歷史低位
機構減倉
最新機構持股923.46K股,環比減少26.43%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉0.00股
活躍度增加
近期活躍度增加,過去20天平均換手率0.27

分析師目標

基於 5 分析師
買入
評級
19.170
目標均價
+121.88%
漲幅空間

electroCore, Inc.新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

electroCore, Inc.簡介

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
公司代碼ECOR
公司electroCore, Inc.
CEOGoldberger (Daniel S)
網址https://www.electrocore.com/

常見問題

electroCore, Inc.(ECOR)的當前股價是多少?

electroCore, Inc.(ECOR)的當前股價是 8.30。

electroCore, Inc. 的股票代碼是什麼?

electroCore, Inc.的股票代碼是ECOR。

electroCore, Inc.股票的52週最高點是多少?

electroCore, Inc.股票的52週最高點是9.68。

electroCore, Inc.股票的52週最低點是多少?

electroCore, Inc.股票的52週最低點是4.16。

electroCore, Inc.的市值是多少?

electroCore, Inc.的市值是68.85M。

現在electroCore, Inc.(ECOR)的股票是買入、持有還是賣出?

根據分析師評級,electroCore, Inc.(ECOR)的總體評級為買入,目標價格為19.17。

electroCore, Inc.(ECOR)股票的每股收益(EPS TTM)是多少

electroCore, Inc.(ECOR)股票的每股收益(EPS TTM)是-1.65。